Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
SCYNEXIS, Inc.

SCYNEXIS, Inc. (SCYX) Stock Overview

Explore SCYNEXIS, Inc.’s financial performance, market position, analyst ratings, and future outlook.

SCYX●NASDAQ
HealthcareMedical - Pharmaceuticals
$5.16
$0.08(1.53%)
U.S. Market opens in 11h 44m

SCYNEXIS, Inc. (SCYX)

Meyka AI Score

Z

Key Financials

Market Cap32.4M
P/E Ratio-1.46
EPS (TTM)$-3.42
ROE-0.57%
Fundamental Analysis

AI Price Forecasts

1 Month$3.86
3 Months$6.81
1 Year Target$5.11

SCYX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of SCYNEXIS, Inc. (NASDAQ: SCYX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, SCYNEXIS, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of SCYX on the NASDAQ shows an RSI of 62.56, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $5.11 for the NASDAQ listing.

Key metrics behind SCYNEXIS, Inc.'s NASDAQ-traded stock include a P/E ratio of -1.46 and a market capitalization of 32.4M. Combined with our AI analysis, these give both institutional and retail investors a clear view of SCYX on the NASDAQ.

Price Performance (NASDAQ: SCYX)

1-Day Change
-1.62%
5-Day Change
-4.36%
1-Month Change
17.69%
3-Month Change
-29.67%
6-Month Change
-20.57%
Year-to-Date (YTD) Change
1.88%
1-Year Change
-26.78%
3-Year Change
-78.45%
5-Year Change
-90.22%
All-Time (Max) Change
-99.28%

Contact Information

https://www.scynexis.com
201 884 5485
1 Evertrust Plaza, Jersey City, NJ, 07302-6548

Company Facts

180 Employees
IPO DateMay 2, 2014
CountryUS
Actively Trading

Frequently Asked Questions